Monica Bertagnolli: A new technique that can accurately detect early molecular changes in DNA code
Monica Bertagnolli shared on LinkedIn:
“A new technique that can accurately detect early molecular changes in DNA code that precede mutations could advance our understanding of the basic causes of mutations, in both healthy cells and in cancer.
More on my blog.”
Source: Monica Bertagnolli/LinkedIn
Monica Bertagnolli is the Director of the National Institute of Health (NIH), USA. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
Dr. Bertagnolli is the Founding Chair of the minimal Common Oncology Data Elements (mCODE) executive committee and has held multiple positions nationally, including being Past President and Chair of the Board of Directors of the American Society of Clinical Oncology, Chair of the Alliance for Clinical Trials in Oncology.
In 2021, she was elected to the National Academy of Medicine, having previously served on the National Academies National Cancer Policy Foru.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023